Evaluation of the Anti-N-Methyl-D-Aspartate Receptor Encephalitis One-Year Functional Status Score in Predicting Functional Outcomes in Pediatric Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis
- 1 November 2021
- journal article
- letter
- Published by Elsevier in Pediatric Neurology
- Vol. 124, 21-23
Abstract
No abstract availableKeywords
Funding Information
- Emory University
This publication has 6 references indexed in Scilit:
- Validation of the NEOS score in Chinese patients with anti-NMDAR encephalitisNeurology Neuroimmunology & Neuroinflammation, 2020
- Pediatric Anti-NMDA-R Encephalitis: Presentation, Diagnosis, and ManagementPediatric Annals, 2019
- A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitisNeurology, 2019
- Anti- N -methyl- d -aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomesJournal of Neuroimmunology, 2017
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyThe Lancet Neurology, 2013
- The Frequency of Autoimmune N-Methyl-D-Aspartate Receptor Encephalitis Surpasses That of Individual Viral Etiologies in Young Individuals Enrolled in the California Encephalitis ProjectClinical Infectious Diseases, 2012